TRFE_HUMAN - dbPTM
TRFE_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TRFE_HUMAN
UniProt AC P02787
Protein Name Serotransferrin
Gene Name TF
Organism Homo sapiens (Human).
Sequence Length 698
Subcellular Localization Secreted.
Protein Description Transferrins are iron binding transport proteins which can bind two Fe(3+) ions in association with the binding of an anion, usually bicarbonate. It is responsible for the transport of iron from sites of absorption and heme degradation to those of storage and utilization. Serum transferrin may also have a further role in stimulating cell proliferation..
Protein Sequence MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
36PhosphorylationAVSEHEATKCQSFRD
EECCCHHHHCHHHHH
29.39-
37AcetylationVSEHEATKCQSFRDH
ECCCHHHHCHHHHHH
37.017679221
37MalonylationVSEHEATKCQSFRDH
ECCCHHHHCHHHHHH
37.0126320211
42MethylationATKCQSFRDHMKSVI
HHHCHHHHHHHHHCC
37.87-
47PhosphorylationSFRDHMKSVIPSDGP
HHHHHHHHCCCCCCC
20.0821406692
51PhosphorylationHMKSVIPSDGPSVAC
HHHHCCCCCCCCEEE
44.0421406692
51O-linked_GlycosylationHMKSVIPSDGPSVAC
HHHHCCCCCCCCEEE
44.04UniProtKB CARBOHYD
55PhosphorylationVIPSDGPSVACVKKA
CCCCCCCCEEEEEEH
28.0721406692
58S-nitrosylationSDGPSVACVKKASYL
CCCCCEEEEEEHHHH
4.2925040305
61GlycationPSVACVKKASYLDCI
CCEEEEEEHHHHHHH
23.36-
63PhosphorylationVACVKKASYLDCIRA
EEEEEEHHHHHHHHH
34.80-
64PhosphorylationACVKKASYLDCIRAI
EEEEEHHHHHHHHHH
16.0622817900
122MalonylationYAVAVVKKDSGFQMN
EEEEEEECCCCCCCH
45.5826320211
122GlycationYAVAVVKKDSGFQMN
EEEEEEECCCCCCCH
45.58-
136PhosphorylationNQLRGKKSCHTGLGR
HHCCCCCCCCCCCCH
18.02-
137S-nitrosylationQLRGKKSCHTGLGRS
HCCCCCCCCCCCCHH
4.5925040305
139PhosphorylationRGKKSCHTGLGRSAG
CCCCCCCCCCCHHCC
38.13-
144PhosphorylationCHTGLGRSAGWNIPI
CCCCCCHHCCCCCCE
29.3630087585
155PhosphorylationNIPIGLLYCDLPEPR
CCCEEEEECCCCCCC
6.75-
207PhosphorylationTLNQYFGYSGAFKCL
HHHHHCCCCCHHHHH
8.2721253578
213S-nitrosylationGYSGAFKCLKDGAGD
CCCCHHHHHCCCCCC
4.6325040305
215GlycationSGAFKCLKDGAGDVA
CCHHHHHCCCCCCEE
64.68-
225AcetylationAGDVAFVKHSTIFEN
CCCEEEEECHHHHHH
25.9427178108
225GlycationAGDVAFVKHSTIFEN
CCCEEEEECHHHHHH
25.94-
227PhosphorylationDVAFVKHSTIFENLA
CEEEEECHHHHHHHC
19.9228857561
246S-nitrosylationRDQYELLCLDNTRKP
HHHHHEEEECCCCCC
7.5825040305
257PhosphorylationTRKPVDEYKDCHLAQ
CCCCCHHHCCCCCCC
13.99-
258GlycationRKPVDEYKDCHLAQV
CCCCHHHCCCCCCCC
52.40-
260S-nitrosylationPVDEYKDCHLAQVPS
CCHHHCCCCCCCCCC
2.1825040305
297GlycationQEHFGKDKSKEFQLF
HHHHCCCCCCCEEEC
67.90-
298PhosphorylationEHFGKDKSKEFQLFS
HHHCCCCCCCEEECC
47.7724719451
299GlycationHFGKDKSKEFQLFSS
HHCCCCCCCEEECCC
69.18-
305PhosphorylationSKEFQLFSSPHGKDL
CCCEEECCCCCCCCC
52.1024719451
306PhosphorylationKEFQLFSSPHGKDLL
CCEEECCCCCCCCCE
17.3724719451
310MalonylationLFSSPHGKDLLFKDS
ECCCCCCCCCEECCC
42.0126320211
315GlycationHGKDLLFKDSAHGFL
CCCCCEECCCCCCCC
51.23-
336NitrationDAKMYLGYEYVTAIR
CCHHCCCHHHHHHHH
11.07-
340PhosphorylationYLGYEYVTAIRNLRE
CCCHHHHHHHHHHCC
18.57-
349PhosphorylationIRNLREGTCPEAPTD
HHHHCCCCCCCCCCC
21.82-
355PhosphorylationGTCPEAPTDECKPVK
CCCCCCCCCCCCCCC
52.02-
355O-linked_GlycosylationGTCPEAPTDECKPVK
CCCCCCCCCCCCCCC
52.02OGP
359AcetylationEAPTDECKPVKWCAL
CCCCCCCCCCCEECC
51.2920167786
364S-nitrosylationECKPVKWCALSHHER
CCCCCCEECCCCCHH
1.9525040305
373MalonylationLSHHERLKCDEWSVN
CCCCHHCCCCCCCCC
45.9526320211
374S-nitrosylationSHHERLKCDEWSVNS
CCCHHCCCCCCCCCC
7.3025040305
389PhosphorylationVGKIECVSAETTEDC
CCEEEEEECCCHHHH
31.8528270605
392PhosphorylationIECVSAETTEDCIAK
EEEEECCCHHHHHHH
34.8928270605
393PhosphorylationECVSAETTEDCIAKI
EEEECCCHHHHHHHH
22.7228270605
396S-nitrosylationSAETTEDCIAKIMNG
ECCCHHHHHHHHHCC
2.3725040305
409O-linked_GlycosylationNGEADAMSLDGGFVY
CCCCCEEECCCCEEE
25.65OGP
430N-linked_GlycosylationLVPVLAENYNKSDNC
CHHHHHCCCCCCCCC
39.8218514042
432N-linked_GlycosylationPVLAENYNKSDNCED
HHHHCCCCCCCCCCC
49.2715084671
432N-linked_GlycosylationPVLAENYNKSDNCED
HHHHCCCCCCCCCCC
49.2715084671
453AcetylationFAIAVVKKSASDLTW
EEEEEEECCHHHCCC
39.3827178108
454PhosphorylationAIAVVKKSASDLTWD
EEEEEECCHHHCCCC
27.5624275569
456PhosphorylationAVVKKSASDLTWDNL
EEEECCHHHCCCCCC
40.0029507054
468PhosphorylationDNLKGKKSCHTAVGR
CCCCCCCCCCCCCCH
18.02-
476PhosphorylationCHTAVGRTAGWNIPM
CCCCCCHHHCCCCCH
24.48-
487PhosphorylationNIPMGLLYNKINHCR
CCCHHHHHCCCCCCC
21.3230631047
491N-linked_GlycosylationGLLYNKINHCRFDEF
HHHHCCCCCCCHHHH
29.8015536627
503S-nitrosylationDEFFSEGCAPGSKKD
HHHHCCCCCCCCCCC
3.4725040305
508AcetylationEGCAPGSKKDSSLCK
CCCCCCCCCCCHHHH
67.527668159
520PhosphorylationLCKLCMGSGLNLCEP
HHHHHCCCCCCCCCC
17.1427251275
525S-nitrosylationMGSGLNLCEPNNKEG
CCCCCCCCCCCCCCC
8.7625040305
533PhosphorylationEPNNKEGYYGYTGAF
CCCCCCCCCCCCCEE
8.5321253578
534PhosphorylationPNNKEGYYGYTGAFR
CCCCCCCCCCCCEEE
17.9527251275
534NitrationPNNKEGYYGYTGAFR
CCCCCCCCCCCCEEE
17.95-
536PhosphorylationNKEGYYGYTGAFRCL
CCCCCCCCCCEEEEE
5.9627273156
537PhosphorylationKEGYYGYTGAFRCLV
CCCCCCCCCEEEEEE
20.0527130503
546AcetylationAFRCLVEKGDVAFVK
EEEEEEECCCEEEEE
53.5926051181
553AcetylationKGDVAFVKHQTVPQN
CCCEEEEEECCCCCC
24.4427178108
553MalonylationKGDVAFVKHQTVPQN
CCCEEEEEECCCCCC
24.4426320211
553GlycationKGDVAFVKHQTVPQN
CCCEEEEEECCCCCC
24.44-
571AcetylationKNPDPWAKNLNEKDY
CCCCHHHHCCCHHCE
59.0927178108
582S-nitrosylationEKDYELLCLDGTRKP
HHCEEEEEECCCCCC
5.2125040305
593PhosphorylationTRKPVEEYANCHLAR
CCCCHHHHHCCHHCC
6.93-
596S-nitrosylationPVEEYANCHLARAPN
CHHHHHCCHHCCCCC
1.8025040305
630N-linked_GlycosylationQQHLFGSNVTDCSGN
CHHHHCCCCCCCCCC
40.8815084671
630N-linked_GlycosylationQQHLFGSNVTDCSGN
CHHHHCCCCCCCCCC
40.8815084671
643PhosphorylationGNFCLFRSETKDLLF
CCEEEEECCCCCEEC
42.1424275569
645PhosphorylationFCLFRSETKDLLFRD
EEEEECCCCCEECCC
30.9823312004
646AcetylationCLFRSETKDLLFRDD
EEEECCCCCEECCCC
42.1827178108
654PhosphorylationDLLFRDDTVCLAKLH
CEECCCCEEEEEECC
19.87-
659MalonylationDDTVCLAKLHDRNTY
CCEEEEEECCCCCHH
33.1526320211
659AcetylationDDTVCLAKLHDRNTY
CCEEEEEECCCCCHH
33.1527178108
659GlycationDDTVCLAKLHDRNTY
CCEEEEEECCCCCHH
33.15-
666PhosphorylationKLHDRNTYEKYLGEE
ECCCCCHHHHHCCHH
17.6122817900
668AcetylationHDRNTYEKYLGEEYV
CCCCHHHHHCCHHHH
35.0527178108
668GlycationHDRNTYEKYLGEEYV
CCCCHHHHHCCHHHH
35.05-
669PhosphorylationDRNTYEKYLGEEYVK
CCCHHHHHCCHHHHH
14.17-
674PhosphorylationEKYLGEEYVKAVGNL
HHHCCHHHHHHHCCH
11.71-
676GlycationYLGEEYVKAVGNLRK
HCCHHHHHHHCCHHH
36.13-
683GlycationKAVGNLRKCSTSSLL
HHHCCHHHCCHHHHH
35.39-
683MalonylationKAVGNLRKCSTSSLL
HHHCCHHHCCHHHHH
35.3926320211
684S-nitrosylationAVGNLRKCSTSSLLE
HHCCHHHCCHHHHHH
4.3025040305
685PhosphorylationVGNLRKCSTSSLLEA
HCCHHHCCHHHHHHH
34.079272172
686PhosphorylationGNLRKCSTSSLLEAC
CCHHHCCHHHHHHHH
31.6329116813
687PhosphorylationNLRKCSTSSLLEACT
CHHHCCHHHHHHHHH
11.6029116813
688PhosphorylationLRKCSTSSLLEACTF
HHHCCHHHHHHHHHC
36.7423312004
694PhosphorylationSSLLEACTFRRP---
HHHHHHHHCCCC---
27.50-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
389SPhosphorylationKinaseFAM20CQ8IXL6
Uniprot
685SPhosphorylationKinaseFAM20CQ8IXL6
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TRFE_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference
58S-nitrosylation55 (3)SRrs8177318
  • Mean corpuscular hemoglobin concentration
  • Mean corpuscular volume
27863252
63Phosphorylation55 (8)SRrs8177318
  • Mean corpuscular hemoglobin concentration
  • Mean corpuscular volume
27863252
64Phosphorylation55 (9)SRrs8177318
  • Mean corpuscular hemoglobin concentration
  • Mean corpuscular volume
27863252
340Phosphorylation343 (3)RWrs150854910
  • Mean corpuscular volume
27863252
349Phosphorylation343 (6)RWrs150854910
  • Mean corpuscular volume
27863252
582S-nitrosylation589 (7)PSrs1049296
  • Alcohol consumption (transferrin glycosylation)
21665994
593Phosphorylation589 (4)PSrs1049296
  • Alcohol consumption (transferrin glycosylation)
21665994
596S-nitrosylation589 (7)PSrs1049296
  • Alcohol consumption (transferrin glycosylation)
21665994

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
IGF1_HUMANIGF1physical
11749962
IGF2_HUMANIGF2physical
11749962
TIM_HUMANTIMELESSphysical
21988832

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
209300Atransferrinemia (ATRAF)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TRFE_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Enrichment of glycopeptides for glycan structure and attachment siteidentification.";
Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,Brinkmalm G., Larson G.;
Nat. Methods 6:809-811(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-432 AND ASN-630, STRUCTUREOF CARBOHYDRATES, AND MASS SPECTROMETRY.
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-432 AND ASN-630, AND MASSSPECTROMETRY.
"Identification of N-linked glycoproteins in human saliva byglycoprotein capture and mass spectrometry.";
Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,Loo J.A.;
J. Proteome Res. 5:1493-1503(2006).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-630, AND MASSSPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-432 AND ASN-630, AND MASSSPECTROMETRY.
"Screening for N-glycosylated proteins by liquid chromatography massspectrometry.";
Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
Proteomics 4:454-465(2004).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-432 AND ASN-630, AND MASSSPECTROMETRY.
"A proteomic analysis of human bile.";
Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H.,Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A.;
Mol. Cell. Proteomics 3:715-728(2004).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-432 AND ASN-630, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-536, AND MASSSPECTROMETRY.

TOP
Application loaded.